Related Experiment Videos
[Comparative study between montmorillonite and Smecta on anti-dysentery effect].
Fengqin Liu1, Weiqiang Zhang, Guihai Li
1Oianfoshan Hospital of Shandong Province, Jinan 250014.
Zhong Yao Cai = Zhongyaocai = Journal of Chinese Medicinal Materials
|February 26, 2003
Summary
Montmorillonite (Mengtuoshi) demonstrates comparable anti-dysentery effects to Smecta. This study suggests Mengtuoshi is a viable alternative for treating dysentery.
Area of Science:
- Pharmacology
- Gastroenterology
Background:
- Dysentery remains a significant health concern globally.
- Developing effective and accessible treatments is crucial.
Purpose of the Study:
- To evaluate and compare the therapeutic efficiency of montmorillonite (Mengtuoshi) against Smecta.
- To determine Mengtuoshi's potential as an anti-dysentery agent.
Main Methods:
- Animal models were used, inducing dysentery in mice using magnesium sulfate, rhubarb powder, and castor oil.
- Different dosages of Mengtuoshi (15.6%, 31.2%) and Smecta (31.2%) were administered.
- The impact on rabbit intestinal over-contraction was also assessed.
Main Results:
- Both Mengtuoshi and Smecta effectively reduced intestinal hypermotility.
- Both agents significantly decreased the frequency of dysentery episodes.
- No significant difference in efficacy was observed between the two treatments at comparable doses.
Conclusions:
- Montmorillonite (Mengtuoshi) exhibits an anti-dysentery effect comparable to Smecta.
- Mengtuoshi presents a promising alternative therapeutic option for managing dysentery.